Progress and perspective of inorganic nanoparticle-based siRNA delivery systems

References

• Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–811. doi:10.1038/35888.
   PubMed Web of Science ®Google Scholar
• Leung RK, Whittaker PA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005;107(2):222–239. doi:10.1016/j.pharmthera.2005.03.004.
   PubMed Web of Science ®Google Scholar
• Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev. 2007;59(2–3):75–86. doi:10.1016/j.addr.2007.03.005.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8(2):129–138. doi:10.1038/nrd2742.
   PubMed Web of Science ®Google Scholar
• Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 2006;13(6):541–552. doi:10.1038/sj.gt.3302703.
   PubMed Web of Science ®Google Scholar
• Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012;19(1):60–71. doi:10.1016/j.chembiol.2011.12.008.
   PubMed Web of Science ®Google Scholar
• Roth L. First evidence of RNA interference mechanism induced in human: getting closer to a cure? Cell Adh Migr. 2011;5(1):1–3.
   PubMed Web of Science ®Google Scholar
• He S, Zhang D, Cheng F, et al. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. Mol Biol Rep. 2009;36(8):2153–2163. doi:10.1007/s11033-008-9429-7.
   PubMed Web of Science ®Google Scholar
• Oh Y-K, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61(10):850–862. doi:10.1016/j.addr.2009.04.018.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 2004;32(19):e149. doi:10.1093/nar/gnh140.
   PubMed Web of Science ®Google Scholar
• Yuan X, Naguib S, Wu Z. Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv. 2011;8(4):521–536. doi:10.1517/17425247.2011.559223.
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, et al. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15(8):541–555. doi:10.1038/nrg3763.
   PubMed Web of Science ®Google Scholar
• Hiruta C, Toyota K, Miyakawa H, et al. Development of a microinjection system for RNA interference in the water flea Daphnia pulex. BMC Biotechnol. 2013;13(1):96. doi:10.1186/1472-6750-13-96.
   PubMed Web of Science ®Google Scholar
• Tomar RS, Matta H, Chaudhary PM. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene. 2003;22(36):5712–5715. doi:10.1038/sj.onc.1206733.
   PubMed Web of Science ®Google Scholar
• Barton GM, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA. 2002;99(23):14943–14945. doi:10.1073/pnas.242594499.
   PubMed Web of Science ®Google Scholar
• Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet. 2007;8(8):573–587. doi:10.1038/nrg2141.
   PubMed Web of Science ®Google Scholar
• Wagner E. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. Acc Chem Res. 2012;45(7):1005–1013. doi:10.1021/ar2002232.
   PubMed Web of Science ®Google Scholar
• Wang M, Alberti K, Varone A, et al. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles. Adv Health Mater. 2014;3(9):1398–1403. doi:10.1002/adhm.v3.9.
   PubMed Web of Science ®Google Scholar
• Galaway FA, Stockley PG. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. Mol Pharm. 2013;10(1):59–68. doi:10.1021/mp3003368.
   PubMed Web of Science ®Google Scholar
• Van Asbeck AH, Beyerle A, McNeill H, et al. Molecular parameters of siRNA–cell penetrating peptide nanocomplexes for efficient cellular delivery. ACS Nano. 2013;7(5):3797–3807. doi:10.1021/nn305754c.
   PubMed Web of Science ®Google Scholar
• Conde J, Ambrosone A, Hernandez Y, et al. 15 years on siRNA delivery: beyond the state-of-the-art on inorganic nanoparticles for RNAi therapeutics. Nano Today. 2015;10:421–450. doi:10.1016/j.nantod.2015.06.008.
   Web of Science ®Google Scholar
• Dominska M, Dykxhoorn DM. Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci. 2010;123(Pt 8):1183–1189. doi:10.1242/jcs.066399.
   PubMed Web of Science ®Google Scholar
• Ma D. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. Nanoscale. 2014;6(12):6415–6425. doi:10.1039/c4nr00018h.
   PubMed Web of Science ®Google Scholar
• Sokolova V, Epple M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed. 2008;47(8):1382–1395. doi:10.1002/(ISSN)1521-3773.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li Y, Yu JC. Chemical modification of inorganic nanostructures for targeted and controlled drug delivery in cancer treatment. J Mater Chem B. 2014;2(5):452–470. doi:10.1039/C3TB21196G.
   PubMed Web of Science ®Google Scholar
• Zhao MX, Zeng EZ, Zhu BJ. The biological applications of inorganic nanoparticle drug carriers. Chem Nano Mat. 2015;1(2):82–91.
   Google Scholar
• Ding Y, Jiang Z, Saha K, et al. Gold nanoparticles for nucleic acid delivery. Mol Ther. 2014;22(6):1075–1083. doi:10.1038/mt.2014.30.
   PubMed Web of Science ®Google Scholar
• Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release. 2011;149(1):65–71. doi:10.1016/j.jconrel.2009.12.006.
   PubMed Web of Science ®Google Scholar
• Han G, Ghosh P, Rotello VM. Functionalized gold nanoparticles for drug delivery. Nanomedicine. 2007;2(1):113–123. doi:10.2217/17435889.2.1.113.
   PubMed Web of Science ®Google Scholar
• Ho D, Sun X, Sun S. Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res. 2011;44(10):875–882. doi:10.1021/ar200090c.
   PubMed Web of Science ®Google Scholar
• Lim E-K, Kim T, Paik S, et al. Nanomaterials for theranostics: recent advances and future challenges. Chem Rev. 2015;115(1):327–394. doi:10.1021/cr300213b.
   PubMed Web of Science ®Google Scholar
• Rana S, Bajaj A, Mout R, et al. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev. 2012;64(2):200–216. doi:10.1016/j.addr.2011.08.006.
   PubMed Web of Science ®Google Scholar
• Jensen SA, Day ES, Ko CH, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013;5(209):209ra152.
   PubMed Web of Science ®Google Scholar
• Randeria PS, Seeger MA, Wang XQ, et al. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. Proc Natl Acad Sci USA. 2015;112(18):5573–5578. doi:10.1073/pnas.1505951112.
   PubMed Web of Science ®Google Scholar
• Huang X, Hu Q, Braun GB, et al. Light-activated RNA interference in human embryonic stem cells. Biomaterials. 2015;63:70–79. doi:10.1016/j.biomaterials.2015.06.006.
   PubMed Web of Science ®Google Scholar
• Lee JS, Green JJ, Love KT, et al. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009;9(6):2402–2406. doi:10.1021/nl9009793.
   PubMed Web of Science ®Google Scholar
• Conde J, Tian F, Hernandez Y, et al. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials. 2013;34(31):7744–7753. doi:10.1016/j.biomaterials.2013.06.041.
   PubMed Web of Science ®Google Scholar
• Son S, Nam J, Kim J, et al. i-Motif-driven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal ablation. ACS Nano. 2014;8(6):5574–5584. doi:10.1021/nn5022567.
   PubMed Web of Science ®Google Scholar
• Kim ST, Chompoosor A, Yeh YC, et al. Dendronized gold nanoparticles for siRNA delivery. Small. 2012;8(21):3253–3256. doi:10.1002/smll.201201141.
   PubMed Web of Science ®Google Scholar
• Lee Y, Lee SH, Kim JS, et al. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J Control Release. 2011;155(1):3–10. doi:10.1016/j.jconrel.2010.09.009.
   PubMed Web of Science ®Google Scholar
• Lee MY, Park SJ, Park K, et al. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano. 2011;5(8):6138–6147. doi:10.1021/nn2017793.
   PubMed Web of Science ®Google Scholar
• Lee SK, Han MS, Asokan S, et al. Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small. 2011;7(3):364–370. doi:10.1002/smll.201001314.
   PubMed Web of Science ®Google Scholar
• Lee SK, Tung C-H. A fabricated siRNA nanoparticle for ultralong gene silencing in vivo. Adv Funct Mater. 2013;23(28):3488–3493. doi:10.1002/adfm.201202777.
   PubMed Web of Science ®Google Scholar
• Guo S, Huang Y, Jiang Q, et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano. 2010;4(9):5505–5511. doi:10.1021/nn101638u.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang G, Zhang R, et al. Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res. 2010;70(8):3177–3188. doi:10.1158/0008-5472.CAN-09-3379.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Tang R, Duncan B, et al. Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules. Angew Chem Int Ed. 2015;54(2):506–510.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee K, Moon SH, et al. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed. 2009;48(23):4174–4179. doi:10.1002/anie.200805998.
   PubMed Web of Science ®Google Scholar
• Kumar M, Yigit M, Dai G, et al. Image-guided breast tumor therapy using a small interfering RNA nanodrug. Cancer Res. 2010;70(19):7553–7561. doi:10.1158/0008-5472.CAN-10-2070.
   PubMed Web of Science ®Google Scholar
• Liu G, Xie J, Zhang F, et al. N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. Small. 2011;7(19):2742–2749. doi:10.1002/smll.201100825.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Min D-H, Singh N, et al. Functional delivery of siRNA in mice using dendriworms. ACS Nano. 2009;3(9):2495–2504. doi:10.1021/nn900201e.
   PubMed Web of Science ®Google Scholar
• Jiang S, Eltoukhy AA, Love KT, et al. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett. 2013;13(3):1059–1064. doi:10.1021/nl304287a.
   PubMed Web of Science ®Google Scholar
• Namiki Y, Namiki T, Yoshida H, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol. 2009;4(9):598–606. doi:10.1038/nnano.2009.202.
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Liong M, et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano. 2009;3(10):3273–3286. doi:10.1021/nn900918w.
   PubMed Web of Science ®Google Scholar
• Li X, Chen Y, Wang M, et al. A mesoporous silica nanoparticle–PEI–fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials. 2013;34(4):1391–1401. doi:10.1016/j.biomaterials.2012.10.072.
   PubMed Web of Science ®Google Scholar
• Kapilov-Buchman Y, Lellouche E, Michaeli S, et al. Unique surface modification of silica nanoparticles with polyethylenimine (PEI) for siRNA delivery using cerium cation coordination chemistry. Bioconjug Chem. 2015;26(5):880–889. doi:10.1021/acs.bioconjchem.5b00100.
   PubMed Web of Science ®Google Scholar
• Ngamcherdtrakul W, Morry J, Gu S, et al. Cationic polymer modified mesoporous silica nanoparticles for targeted siRNA delivery to HER2+ breast cancer. Adv Funct Mater. 2015;25(18):2646–2659. doi:10.1002/adfm.201404629.
   PubMed Web of Science ®Google Scholar
• Chen AM, Zhang M, Wei D, et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small. 2009;5(23):2673–2677. doi:10.1002/smll.200900621.
   PubMed Web of Science ®Google Scholar
• Meng H, Mai WX, Zhang H, et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 2013;7(2):994–1005. doi:10.1021/nn3044066.
   PubMed Web of Science ®Google Scholar
• Pittella F, Zhang M, Lee Y, et al. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials. 2011;32(11):3106–3114. doi:10.1016/j.biomaterials.2010.12.057.
   PubMed Web of Science ®Google Scholar
• Lee MS, Lee JE, Byun E, et al. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa–hyaluronic acid conjugate. J Control Release. 2014;192:122–130. doi:10.1016/j.jconrel.2014.06.049.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Huang L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J Control Release. 2012;158(1):108–114. doi:10.1016/j.jconrel.2011.10.020.
   PubMed Web of Science ®Google Scholar
• Oishi M, Nakaogami J, Ishii T, et al. Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett. 2006;35(9):1046–1047. doi:10.1246/cl.2006.1046.
   Web of Science ®Google Scholar
• Giljohann DA, Seferos DS, Prigodich AE, et al. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc. 2009;131(6):2072–2073. doi:10.1021/ja808719p.
   PubMed Web of Science ®Google Scholar
• Zheng D, Giljohann DA, Chen DL, et al. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci USA. 2012;109(30):11975–11980. doi:10.1073/pnas.1118425109.
   PubMed Web of Science ®Google Scholar
• Song W-J, Du J-Z, Sun T-M, et al. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small. 2010;6(2):239–246. doi:10.1002/smll.200901513.
   PubMed Web of Science ®Google Scholar
• Elbakry A, Zaky A, Liebl R, et al. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009;9(5):2059–2064. doi:10.1021/nl9003865.
   PubMed Web of Science ®Google Scholar
• Han L, Zhao J, Zhang X, et al. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano. 2012;6(8):7340–7351. doi:10.1021/nn3024688.
   PubMed Web of Science ®Google Scholar
• Gilleron J, Querbes W, Zeigerer A, et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol. 2013;31(7):638–646. doi:10.1038/nbt.2612.
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang Y, Zhou J, et al. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Biomaterials. 2014;35(25):7214–7227. doi:10.1016/j.biomaterials.2014.05.009.
   PubMed Web of Science ®Google Scholar
• Benjaminsen RV, Mattebjerg MA, Henriksen JR, et al. The possible proton sponge effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther. 2013;21(1):149–157. doi:10.1038/mt.2012.185.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Ito E, Akita H, et al. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release. 2009;139(2):127–132. doi:10.1016/j.jconrel.2009.06.008.
   PubMed Web of Science ®Google Scholar
• Park JW, Bae KH, Kim C, et al. Clustered magnetite nanocrystals cross-linked with PEI for efficient siRNA delivery. Biomacromolecules. 2011;12(2):457–465. doi:10.1021/bm101244j.
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Wu C-W, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278–1288. doi:10.1016/j.addr.2008.03.012.
   PubMed Web of Science ®Google Scholar
• Bhattarai S, Muthuswamy E, Wani A, et al. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharm Res. 2010;27(12):2556–2568. doi:10.1007/s11095-010-0245-0.
   PubMed Web of Science ®Google Scholar
• Hartono SB, Gu W, Kleitz F, et al. Poly-l-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano. 2012;6(3):2104–2117. doi:10.1021/nn2039643.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhao Y, Ng KW, et al. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Chem J Eur. 2013;19(46):15593–15603. doi:10.1002/chem.201302736.
   PubMed Web of Science ®Google Scholar
• Roy I, Mitra S, Maitra A, et al. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm. 2003;250(1):25–33.
   PubMed Web of Science ®Google Scholar